News
Learn about COPD medications, including bronchodilators, steroids, and combination treatments. ... which helps loosen thick mucus and may also reduce inflammation in the airways.
8d
HealthDay on MSNCystic Fibrosis: Symptoms, Treatments, Causes & MoreCystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...
17d
Health on MSNWhat Causes Brown Mucus?Medically reviewed by Amelia MacIntyre, DO Mucus, a fluid in your upper respiratory system, is usually clear. But a number of health conditions can cause it to turn brown. Also known as brown phlegm ...
WE’RE all aware that chest pain is a common sign that something’s wrong with our heart. But it’s far from the only signal, ...
Excessive mucus production is increasingly recognised as an important factor in COPD, though its precise role in the pathogenesis of the disease is not fully understood. 28-31 Recent studies have ...
Yoga . A number of small studies suggest that yoga may be beneficial for people who have COPD. One 2014 review in the Journal of Thoracic Disease reported positive effects for people with COPD who ...
Miami (June 17, 2025) – Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study. The study is published in the ...
COPD has a large economic impact on the healthcare system and a destructive impact on the lives of patients and their ...
The Hailie Smartinhaler device has also been cleared for use with inhalers from other manufacturers, including GSK, Boehringer Ingelheim, and Teva, and Adherium also sells the device directly to ...
Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms.
The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 billion by 2034. The Industry is expected to surge at a CAGR of 3.70% from ...
Lupin has signed a licensing deal with China’s Sino Universal Pharmaceuticals to bring its Tiotropium inhaler to the Chinese market. The product, used for treating COPD, will be manufactured by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results